These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8445496)

  • 1. Validation of environmental monitoring methods and levels.
    Noble NH
    J Parenter Sci Technol; 1993; 47(1):26-8. PubMed ID: 8445496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigational trends: clean room environmental monitoring.
    Tetzlaff RF
    J Parenter Sci Technol; 1992; 46(6):206-14. PubMed ID: 1474432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shipshape: sanitation inspections on cruise ships, 1990-2005, Vessel Sanitation Program, Centers for Disease Control and Prevention.
    Cramer EH; Blanton CJ; Otto C
    J Environ Health; 2008 Mar; 70(7):15-21. PubMed ID: 18348387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current regulatory issues regarding parenteral inspections.
    Avallone H
    J Parenter Sci Technol; 1989; 43(1):3-7. PubMed ID: 2926605
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbiological validation of a new manufacturing complex for an injectable biological product.
    Carroll MC; Van Pala M; Vollherbst L
    J Parenter Sci Technol; 1992; 46(4):107-10. PubMed ID: 1453278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industrial hygiene in the pharmaceutical industry.
    Guest I; Newton D
    Occup Med; 1997; 12(1):81-94. PubMed ID: 9153054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerial monitoring of marine waterfowl in the Alaskan Beaufort Sea.
    Johnson SR; Noel LE; Gazey WJ; Hawkes VC
    Environ Monit Assess; 2005 Sep; 108(1-3):1-43. PubMed ID: 16160776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten steps to ensure a successful preNDA approval inspection.
    Justice RM; Rodriguez JO; Chiasson WJ
    J Parenter Sci Technol; 1993; 47(2):89-92. PubMed ID: 8515350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and environmental monitoring of aseptic processing. Committee on Microbial Purity.
    J Parenter Sci Technol; 1990; 44(5):272-7. PubMed ID: 2250203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the scope of bioluminiscence in pharmaceutical clean rooms monitoring?
    Temprano GC; D'Aquino M
    Boll Chim Farm; 2003 Sep; 142(7):274-6. PubMed ID: 14677270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine industry perspective of current issues of good manufacturing practices regarding product inspections and stability testing.
    Monahan TR
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S356-61. PubMed ID: 11709773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boundary and airlock design issues in aseptic facilities.
    Lorenz MR; Robinson JE
    J Parenter Sci Technol; 1991; 45(6):279-85. PubMed ID: 1802984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleanroom airborne particulate limits and 70% isopropyl alcohol: a lingering problem for pharmaceutical manufacturing?
    Eaton T
    PDA J Pharm Sci Technol; 2009; 63(6):559-67. PubMed ID: 20169862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of absorbed dose estimates derived from passive dosimetry measurements to those derived from biological monitoring: validation of exposure monitoring methodologies.
    Ross J; Chester G; Driver J; Lunchick C; Holden L; Rosenheck L; Barnekow D
    J Expo Sci Environ Epidemiol; 2008 Mar; 18(2):211-30. PubMed ID: 17593947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microbiologic validation in the production of sterile pharmaceuticals].
    Pongiluppi S
    Boll Chim Farm; 1991 Jun; 130(6):203-12. PubMed ID: 1756004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assurance operations: good clinical practices.
    Castellion AW
    Drug Inf J; 1983; 17(1):25-9. PubMed ID: 10262248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and implementation of model based control strategies at an industrial wastewater treatment plant.
    Demey D; Vanderhaegen B; Vanhooren H; Liessens J; Van Eyck L; Hopkins L; Vanrolleghem PA
    Water Sci Technol; 2001; 44(2-3):145-53. PubMed ID: 11547977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?
    Hewitt NJ; de Kanter R; LeCluyse E
    Chem Biol Interact; 2007 May; 168(1):51-65. PubMed ID: 17239835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal for a new categorization of aseptic processing facilities based on risk assessment scores.
    Katayama H; Toda A; Tokunaga Y; Katoh S
    PDA J Pharm Sci Technol; 2008; 62(4):235-43. PubMed ID: 19174952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A centralized system of particle counting in controlled zones].
    Hervieux D
    Boll Chim Farm; 1991 Jun; 130(6):218-21. PubMed ID: 1756006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.